HIGHCAPE PARTNERS MANAGEMENT, L.P.
HIGHCAPE PARTNERS MANAGEMENT, L.P. is a Seed, Series A, Series B, Series C+, commercial-stage, early-revenue, product-launch and venture fund in the US investing in life-sciences, healthcare-tech, biotechnology, medical-devices, oncology, proteomics, surgical-reconstruction, cardiac-monitoring, respiratory-wellness, drug-delivery and drug-eluting-biomaterials.
- Stages
- Seed, Series A, Series B, Series C+, commercial-stage, early-revenue, product-launch, venture
- Sectors
- life-sciences, healthcare-tech, biotechnology, medical-devices, oncology, proteomics, surgical-reconstruction, cardiac-monitoring, respiratory-wellness, drug-delivery, drug-eluting-biomaterials
- Invests in
- US-wide
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2013
- Assets under management
- $145M
- Website
- highcape.com
Check size not disclosed
Thesis
HighCape Partners Management, L.P. is a growth equity firm founded in 2013, specializing in the life sciences sector. They focus on investing in commercial-stage companies with superior products, a clear path to commercialization, and a demonstrable value proposition for the healthcare system. Their primary geographic scope is the United States. The firm's investment thesis is to support innovative life sciences companies in their transition to successful, thriving organizations. As of June 30, 2020, HighCape Partners had approximately $145 million in assets under management. Their initial fund, closed in September 2015, was $80 million. They aim to invest in six to eight companies per fund.
Common questions
Does HIGHCAPE PARTNERS MANAGEMENT, L.P. invest at the Seed stage?
Yes. HIGHCAPE PARTNERS MANAGEMENT, L.P. lists Seed, Series A, Series B, Series C+, commercial-stage, early-revenue, product-launch and venture among the stages it invests in.
Where does HIGHCAPE PARTNERS MANAGEMENT, L.P. invest?
HIGHCAPE PARTNERS MANAGEMENT, L.P. invests in the US.